{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T14:57:05Z","timestamp":1785855425758,"version":"3.56.0"},"reference-count":42,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,7]]},"DOI":"10.1097\/mnm.0000000000001024","type":"journal-article","created":{"date-parts":[[2019,5,6]],"date-time":"2019-05-06T16:45:51Z","timestamp":1557161151000},"page":"734-743","source":"Crossref","is-referenced-by-count":12,"title":["A comparison of visual and semiquantitative analysis methods for planar cardiac 123I-MIBG scintigraphy in dementia with Lewy bodies"],"prefix":"10.1097","volume":"40","author":[{"given":"Gemma","family":"Roberts","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph P.M.","family":"Kane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jim J.","family":"Lloyd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George S.","family":"Petrides","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kim","family":"Howe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John T.","family":"O\u2019Brien","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan J.","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-10-20210212","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1017\/S0033291713000494","article-title":"The prevalence and incidence of dementia with Lewy bodies: a systematic review of population and clinical studies","volume":"44","author":"Vann Jones","year":"2014","journal-title":"Psychol Med"},{"key":"R2-10-20210212","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/s13195-018-0350-6","article-title":"Clinical prevalence of Lewy body dementia","volume":"10","author":"Kane","year":"2018","journal-title":"Alzheimers Res Ther"},{"key":"R3-10-20210212","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1111\/j.1468-1331.2008.02388.x","article-title":"Differences in clinical course between dementia with Lewy bodies and Alzheimer\u2019s disease","volume":"16","author":"Hanyu","year":"2009","journal-title":"Eur J Neurol"},{"key":"R4-10-20210212","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1002\/gps.3799","article-title":"Examining carer stress in dementia: the role of subtype diagnosis and neuropsychiatric symptoms","volume":"28","author":"Lee","year":"2013","journal-title":"Int J Geriatr Psychiatry"},{"key":"R5-10-20210212","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/j.parkreldis.2010.03.007","article-title":"Lewy body dementia: the caregiver experience of clinical care","volume":"16","author":"Galvin","year":"2010","journal-title":"Parkinsonism Relat Disord"},{"key":"R6-10-20210212","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1212\/WNL.0000000000004058","article-title":"Diagnosis and management of dementia with Lewy bodies: Fourth consensus report of the DLB Consortium","volume":"89","author":"McKeith","year":"2017","journal-title":"Neurology"},{"key":"R7-10-20210212","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1186\/alzrt274","article-title":"The clinical characteristics of dementia with Lewy bodies and a consideration of prodromal diagnosis","volume":"6","author":"Donaghy","year":"2014","journal-title":"Alzheimers Res Ther"},{"key":"R8-10-20210212","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1212\/WNL.0000000000003512","article-title":"Autopsy validation of 123I-FP-CIT dopaminergic neuroimaging for the diagnosis of DLB","volume":"88","author":"Thomas","year":"2017","journal-title":"Neurology"},{"key":"R9-10-20210212","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1177\/0891988716654984","article-title":"Imaging in dementia with Lewy bodies: an overview","volume":"29","author":"Watson","year":"2016","journal-title":"J Geriatr Psychiatry Neurol"},{"key":"R10-10-20210212","doi-asserted-by":"crossref","first-page":"2798","DOI":"10.1093\/brain\/aws211","article-title":"Neuropathological correlates of dopaminergic imaging in Alzheimer\u2019s disease and Lewy body dementias","volume":"135","author":"Colloby","year":"2012","journal-title":"Brain"},{"key":"R11-10-20210212","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/S1474-4422(07)70057-1","article-title":"Sensitivity and specificity of dopamine transporter imaging with 123I-FP-CIT SPECT in dementia with Lewy bodies: a phase III, multicentre study.","volume":"6","author":"McKeith","year":"2007","journal-title":"Lancet Neurol"},{"key":"R12-10-20210212","doi-asserted-by":"crossref","first-page":"1850","DOI":"10.1212\/01.wnl.0000219640.59984.a7","article-title":"Value of 123I-MIBG radioactivity in the differential diagnosis of DLB from AD","volume":"66","author":"Yoshita","year":"2006","journal-title":"Neurology"},{"key":"R13-10-20210212","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1007\/s00259-008-0828-8","article-title":"Cardiac (123)I-metaiodobenzylguanidine imaging allows early identification of dementia with Lewy bodies during life","volume":"35","author":"Estorch","year":"2008","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"R14-10-20210212","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1159\/000095641","article-title":"The role of 123I-metaiodobenzylguanidine myocardial scintigraphy in the diagnosis of Lewy body disease in patients with dementia in a memory clinic","volume":"22","author":"Hanyu","year":"2006","journal-title":"Dement Geriatr Cogn Disord"},{"key":"R15-10-20210212","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1002\/gps.4229","article-title":"Diagnostic value of MIBG cardiac scintigraphy for differential dementia diagnosis","volume":"30","author":"Slaets","year":"2015","journal-title":"Int J Geriatr Psychiatry"},{"key":"R16-10-20210212","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1111\/j.1552-6569.2010.00532.x","article-title":"Diagnostic performance of myocardial innervation imaging using MIBG scintigraphy in differential diagnosis between dementia with lewy bodies and other dementias: a systematic review and a meta-analysis","volume":"22","author":"Treglia","year":"2012","journal-title":"J Neuroimaging"},{"key":"R17-10-20210212","doi-asserted-by":"crossref","first-page":"e0120540","DOI":"10.1371\/journal.pone.0120540","article-title":"Diagnostic accuracy of 123I-meta-iodobenzylguanidine myocardial scintigraphy in dementia with Lewy bodies: a multicenter study","volume":"10","author":"Yoshita","year":"2015","journal-title":"PLoS One"},{"key":"R18-10-20210212","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1136\/jnnp-2017-317398","article-title":"(123)I-MIBG myocardial scintigraphy for the diagnosis of DLB: a multicentre 3-year follow-up study","volume":"89","author":"Komatsu","year":"2018","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"R19-10-20210212","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1007\/s40336-017-0230-2","article-title":"Standardization of 123I-meta-iodobenzylguanidine myocardial sympathetic activity imaging: phantom calibration and clinical applications","volume":"5","author":"Nakajima","year":"2017","journal-title":"Clin Transl Imaging"},{"key":"R20-10-20210212","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1007\/s00259-011-1783-3","article-title":"Vascular time-activity variation in patients undergoing 123I-MIBG myocardial scintigraphy: implications for quantification of cardiac and mediastinal uptake","volume":"38","author":"Verberne","year":"2011","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"R21-10-20210212","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1097\/MNM.0000000000000238","article-title":"123I-MIBG heart-to-mediastinum ratio is influenced by high-energy photon penetration of collimator septa from liver and lung activity","volume":"36","author":"Verschure","year":"2015","journal-title":"Nucl Med Commun"},{"key":"R22-10-20210212","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1007\/s12350-017-0782-6","article-title":"A European myocardial 123I-mIBG cross-calibration phantom study","volume":"25","author":"Verschure","year":"20178","journal-title":"J Nucl Cardiol"},{"key":"R23-10-20210212","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1007\/s12350-014-9943-z","article-title":"Quantification of I-123-meta-iodobenzylguanidine heart-to-mediastinum ratios: not so simple after all","volume":"21","author":"Slomka","year":"2014","journal-title":"J Nucl Cardiol"},{"key":"R24-10-20210212","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1007\/s12350-016-0708-8","article-title":"Influence of ROI definition on the heart-to-mediastinum ratio in planar 123I-MIBG imaging","volume":"25","author":"Klene","year":"2018","journal-title":"J Nucl Cardiol"},{"key":"R25-10-20210212","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1007\/s00259-011-1963-1","article-title":"Standardization of metaiodobenzylguanidine heart to mediastinum ratio using a calibration phantom: effects of correction on normal databases and a multicentre study","volume":"39","author":"Nakajima","year":"2012","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"R26-10-20210212","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1111\/j.1552-6569.2012.00774.x","article-title":"Iodine-123 metaiodobenzylguanidine scintigraphy and iodine-123 ioflupane single photon emission computed tomography in Lewy body diseases: complementary or alternative techniques?","volume":"24","author":"Treglia","year":"2014","journal-title":"J Neuroimaging"},{"key":"R27-10-20210212","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1002\/ana.24717","article-title":"(123) I-2beta-carbomethoxy-3beta-(4-iodophenyl)-N-(3-fluoropropyl) nortropane single photon emission computed tomography and (123) I-metaiodobenzylguanidine myocardial scintigraphy in differentiating dementia with lewy bodies from other dementias: A comparative study","volume":"80","author":"Tiraboschi","year":"2016","journal-title":"Ann Neurol"},{"key":"R28-10-20210212","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1007\/s12350-010-9313-4","article-title":"Semi-automated algorithm for calculating heart-to-mediastinum ratio in cardiac Iodine-123 MIBG imaging","volume":"18","author":"Okuda","year":"2011","journal-title":"J Nucl Cardiol"},{"key":"R29-10-20210212","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1007\/s11886-010-0157-y","article-title":"Variation of heart-to-mediastinal ratio in 123I-mIBG cardiac sympathetic imaging: its affecting factors and potential corrections","volume":"13","author":"Chen","year":"2011","journal-title":"Curr Cardiol Rep"},{"key":"R30-10-20210212","doi-asserted-by":"crossref","first-page":"20160144","DOI":"10.1259\/bjr.20160144","article-title":"123I-MIBG myocardial scintigraphy for the evaluation of Lewy body disease: are delayed images essential? Is visual assessment useful?","volume":"89","author":"Sakamoto","year":"2016","journal-title":"Br J Radiol"},{"key":"R31-10-20210212","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.arr.2016.01.001","article-title":"(123)I-meta-iodobenzylguanidine (MIBG) cardiac scintigraphy in alpha-synucleinopathies","volume":"30","author":"Orimo","year":"2016","journal-title":"Ageing Res Rev"},{"key":"R32-10-20210212","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1097\/MNM.0000000000000271","article-title":"Comparison of the diagnostic performance of H\/M ratio between early and delayed phases for Lewy body disease","volume":"36","author":"Maruyama","year":"2015","journal-title":"Nucl Med Commun"},{"key":"R33-10-20210212","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.pscychresns.2016.12.011","article-title":"123I-metaiodobenzylguanidine myocardial scintigraphy with early images alone is useful for the differential diagnosis of dementia with Lewy bodies","volume":"261","author":"Manabe","year":"2017","journal-title":"Psychiatry Res"},{"key":"R35-10-20210212","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1212\/WNL.54.5.1050","article-title":"Predictive accuracy of clinical diagnostic criteria for dementia with lewy bodies: a prospective neuropathological validation study","volume":"54","author":"McKeith","year":"2000","journal-title":"Neurology"},{"key":"R36-10-20210212","doi-asserted-by":"crossref","first-page":"1802","DOI":"10.1007\/s00259-010-1491-4","article-title":"Proposal for standardization of 123I-metaiodobenzylguanidine (MIBG) cardiac sympathetic imaging by the EANM Cardiovascular Committee and the European Council of Nuclear Cardiology","volume":"37","author":"Flotats","year":"2010","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"R37-10-20210212","doi-asserted-by":"crossref","first-page":"S81","DOI":"10.1002\/ana.21455","article-title":"Parkinson\u2019s disease dementia: definitions, guidelines, and research perspectives in diagnosis","volume":"64","author":"Goetz","year":"2008","journal-title":"Ann Neurol"},{"key":"R38-10-20210212","first-page":"437","article-title":"Characteristics and regulation of 123I-MIBG transport in cultured pulmonary endothelial cells","volume":"47","author":"Lee","year":"2006","journal-title":"J Nucl Med"},{"key":"R39-10-20210212","first-page":"1747","article-title":"In vivo evidence of endothelial injury in chronic obstructive pulmonary disease by lung scintigraphic assessment of 123I metaiodobenzylguanidine","volume":"44","author":"Arao","year":"2003","journal-title":"J Nucl Med"},{"key":"R40-10-20210212","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1007\/s12149-013-0741-5","article-title":"Clinical significance of lung iodine-123 metaiodobenzylguanidine uptake assessment in Parkinson\u2019s and heart diseases","volume":"27","author":"Nakae","year":"2013","journal-title":"Ann Nucl Med"},{"key":"R41-10-20210212","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1212\/01.WNL.0000055899.24594.8E","article-title":"Effect of l-DOPA on plasma homocysteine in PD patients: relationship to B-vitamin status","volume":"60","author":"Miller","year":"2003","journal-title":"Neurology"},{"key":"R42-10-20210212","doi-asserted-by":"crossref","first-page":"51","DOI":"10.3988\/jcn.2006.2.1.51","article-title":"Clinical implications of cardiac-MIBG SPECT in the differentiation of parkinsonian syndromes","volume":"2","author":"Shin","year":"2006","journal-title":"J Clin Neurol"},{"key":"R43-10-20210212","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1097\/00006231-199802000-00007","article-title":"Decreased myocardial accumulation of 123I-meta-iodobenzyl guanidine in Parkinson\u2019s disease","volume":"19","author":"Yoshita","year":"1998","journal-title":"Nucl Med Commun"}],"container-title":["Nuclear Medicine Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/MNM.0000000000001024","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T14:38:27Z","timestamp":1785854307000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00006231-201907000-00010"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7]]},"references-count":42,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2019]]}},"URL":"https:\/\/doi.org\/10.1097\/mnm.0000000000001024","relation":{},"ISSN":["0143-3636"],"issn-type":[{"value":"0143-3636","type":"print"}],"subject":[],"published":{"date-parts":[[2019,7]]}}}